# Low-Dose Naltrexone and Acetaminophen Combination and Sumatriptan in the Acute Treatment of Migraine With Nausea

> **NCT03185143** · PHASE2,PHASE3 · COMPLETED · sponsor: **Allodynic Therapeutics, Inc** · enrollment: 36 (actual)

## Conditions studied

- Migraine With and Without Aura

## Interventions

- **DRUG:** Naltrexone and Acetaminophen Combination
- **DRUG:** Sumatriptan 100 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03185143
- **Lead sponsor:** Allodynic Therapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-27
- **Primary completion:** 2018-05-07
- **Final completion:** 2018-05-07
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2021-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03185143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03185143, "Low-Dose Naltrexone and Acetaminophen Combination and Sumatriptan in the Acute Treatment of Migraine With Nausea". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03185143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*